-
1
-
-
42949119308
-
Continuous infusion of beta-lactams in the intensive care unit - Best way to hit the target?
-
Roberts JA, Paratz JD, Lipman J: Continuous infusion of beta-lactams in the intensive care unit - Best way to hit the target? Crit Care Med 2008; 36:1663-1664
-
(2008)
Crit Care Med
, vol.36
, pp. 1663-1664
-
-
Roberts, J.A.1
Paratz, J.D.2
Lipman, J.3
-
3
-
-
0033847562
-
Establishment of Pseudomonas aeruginosa infection: Lessons from a versatile opportunist
-
Lyczak JB, Cannon CL, Pier GB: Establishment of Pseudomonas aeruginosa infection: Lessons from a versatile opportunist. Microbes Infect 2000; 2:1051-1060
-
(2000)
Microbes Infect
, vol.2
, pp. 1051-1060
-
-
Lyczak, J.B.1
Cannon, C.L.2
Pier, G.B.3
-
4
-
-
33644509227
-
Targeting mechanisms of Pseudomonas aeruginosa pathogenesis
-
Kipnis E, Sawa T, Wiener-Kronish J: Targeting mechanisms of Pseudomonas aeruginosa pathogenesis. Med Mal Infect 2006; 36:78-91
-
(2006)
Med Mal Infect
, vol.36
, pp. 78-91
-
-
Kipnis, E.1
Sawa, T.2
Wiener-Kronish, J.3
-
5
-
-
67650416003
-
Exoproduct secretions of P. aeruginosa strains influence severity of alveolar epithelial injury
-
Kudoh I, Wiener-Kronish JP, Hashimoto S, et al: Exoproduct secretions of P. aeruginosa strains influence severity of alveolar epithelial injury. Am J Physiol 1995; 268:181-186
-
(1995)
Am J Physiol
, vol.268
, pp. 181-186
-
-
Kudoh, I.1
Wiener-Kronish, J.P.2
Hashimoto, S.3
-
6
-
-
0032699215
-
Pathogenesis of septic shock in P. aeruginosa pneumonia
-
Kurahashi K, Kajikawa O, Sawa T, et al: Pathogenesis of septic shock in P. aeruginosa pneumonia. J Clin Invest 1999; 104: 743-750
-
(1999)
J Clin Invest
, vol.104
, pp. 743-750
-
-
Kurahashi, K.1
Kajikawa, O.2
Sawa, T.3
-
7
-
-
53049087805
-
Increased mortality of ventilated patients with endotracheal Pseudomonas aeruginosa without clinical signs of infection
-
Zhuo H, Yang K, Lynch SV, et al: Increased mortality of ventilated patients with endotracheal Pseudomonas aeruginosa without clinical signs of infection. Crit Care Med 2008; 36:2495-2503
-
(2008)
Crit Care Med
, vol.36
, pp. 2495-2503
-
-
Zhuo, H.1
Yang, K.2
Lynch, S.V.3
-
8
-
-
0032907634
-
Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury
-
Sawa T, Yahr TL, Ohara M, et al: Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat Med 1999; 5:392-398
-
(1999)
Nat Med
, vol.5
, pp. 392-398
-
-
Sawa, T.1
Yahr, T.L.2
Ohara, M.3
-
9
-
-
40549120627
-
Quorum-sensing activity and related virulence factor expression in clinically pathogenic isolates of Pseudomonas aeruginosa
-
Le Berre R, Nguyen S, Nowak E, et al: Quorum-sensing activity and related virulence factor expression in clinically pathogenic isolates of Pseudomonas aeruginosa. Clin Microbiol Infect 2008; 14:337-343
-
(2008)
Clin Microbiol Infect
, vol.14
, pp. 337-343
-
-
Le Berre, R.1
Nguyen, S.2
Nowak, E.3
-
10
-
-
0032879168
-
Pseudomonas aeruginosa induces type III secretion-mediated apoptosis of macrophages and epithelial cells
-
Hauser AR, Engel JN: Pseudomonas aeruginosa induces type III secretion-mediated apoptosis of macrophages and epithelial cells. Infect Immun 1999; 67:5530-5537
-
(1999)
Infect Immun
, vol.67
, pp. 5530-5537
-
-
Hauser, A.R.1
Engel, J.N.2
-
11
-
-
0036191393
-
Type III protein secretion is associated with poor clinical outcomes in patients with ventilatorassociated pneumonia caused by Pseudomonas aeruginosa
-
Hauser AR, Cobb E, Bodi M, et al: Type III protein secretion is associated with poor clinical outcomes in patients with ventilatorassociated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med 2002; 30: 521-528
-
(2002)
Crit Care Med
, vol.30
, pp. 521-528
-
-
Hauser, A.R.1
Cobb, E.2
Bodi, M.3
-
12
-
-
0033591446
-
Type III secretion machines: Bacterial devices for protein delivery into host cells
-
Galan JE, Collmer A: Type III secretion machines: Bacterial devices for protein delivery into host cells. Science 1999; 284:1322-1328
-
(1999)
Science
, vol.284
, pp. 1322-1328
-
-
Galan, J.E.1
Collmer, A.2
-
13
-
-
0035889948
-
Therapeutic administration of anti-PcrV F(ab′)(2) in sepsis associated with Pseudomonas aeruginosa
-
Shime N, Sawa T, Fujimoto J, et al: Therapeutic administration of anti-PcrV F(ab′)(2) in sepsis associated with Pseudomonas aeruginosa. J Immunol 2001; 167:5880-5886
-
(2001)
J Immunol
, vol.167
, pp. 5880-5886
-
-
Shime, N.1
Sawa, T.2
Fujimoto, J.3
-
14
-
-
0035877065
-
Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections
-
Roy-Burman A, Savel RH, Racine S, et al: Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis 2001; 183:1767-1774
-
(2001)
J Infect Dis
, vol.183
, pp. 1767-1774
-
-
Roy-Burman, A.1
Savel, R.H.2
Racine, S.3
-
15
-
-
15944399760
-
Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge
-
Neely AN, Holder IA, Wiener-Kronish JP, et al: Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge. Burns 2005; 31:153-158
-
(2005)
Burns
, vol.31
, pp. 153-158
-
-
Neely, A.N.1
Holder, I.A.2
Wiener-Kronish, J.P.3
-
16
-
-
34248201529
-
Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model
-
Imamura Y, Yanagihara K, Fukuda Y, et al: Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model. Eur Respir J 2007; 29:965-968
-
(2007)
Eur Respir J
, vol.29
, pp. 965-968
-
-
Imamura, Y.1
Yanagihara, K.2
Fukuda, Y.3
-
17
-
-
34250622826
-
Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa
-
Flanagan JL, Brodie EL, Weng L, et al: Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa. J Clin Microbiol 2007; 45:1954-1962
-
(2007)
J Clin Microbiol
, vol.45
, pp. 1954-1962
-
-
Flanagan, J.L.1
Brodie, E.L.2
Weng, L.3
-
18
-
-
0031900022
-
Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: Relapse or reinfection?
-
Rello J, Mariscal D, March F, et al: Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: Relapse or reinfection? Am J Respir Crit Care Med 1998; 157:912-916
-
(1998)
Am J Respir Crit Care Med
, vol.157
, pp. 912-916
-
-
Rello, J.1
Mariscal, D.2
March, F.3
-
19
-
-
34247149303
-
Does this patient have ventilator-associated pneumonia?
-
Klompas M: Does this patient have ventilator-associated pneumonia? JAMA 2007; 297: 1583-1593
-
(2007)
JAMA
, vol.297
, pp. 1583-1593
-
-
Klompas, M.1
|